Company: ALM
Filing Date: 2025-07-07
Form Type: F-10
Source: 0001641172-25-017947
Chunk: 60

Company: Almonty Industries Inc.
Filing Date: 2025-07-07
Form: F-10
Chunk 60
---
’s ability to raise additional capital through the sale of securities should the Company desire
to do so.

Liquidity of the Market for the Common
Shares

Shareholders of the
Company may be unable to sell significant quantities of Common Shares into the public trading markets without a significant reduction
in the price of their Common Shares, or at all. There can be no assurance that there will be sufficient liquidity of the Common Shares
on the trading market, and that the Company will continue to meet the listing requirements of the TSX and ASX, or the trading requirements
of the FSE, or achieve listing on any other public listing exchange, including the NASDAQ.

Securities or Industry Analysts’
Research

The trading market
for the Common Shares will depend, in part, on the research and reports that securities or industry analysts publish about us or our
business. If one or more of the analysts who cover the Company downgrade our Common Shares or publish inaccurate or unfavourable research
about its business, the Common Shares price would likely decline. In addition, if the operating results fail to meet the forecast of
analysts, the Common Shares price would likely decline. If one or more of these analysts cease coverage of the Company or fail to publish
reports on regularly, demand for the Common Shares could decrease, which might cause the Common Shares price and trading volume to decline.

| 33 |

Treatment as an “Emerging Growth
Company”

We are an “emerging growth company,”
as defined in the JOBS Act. For as long as we continue to be an emerging growth company, we may take advantage of exemptions from various
reporting requirements that are applicable to other public companies that are not emerging growth companies, including, but not limited
to, (1) not being required to comply with the auditor attestation requirements of Section 404 of the United States Sarbanes-Oxley
Act of 2002, or the Sarbanes-Oxley Act, (2) reduced disclosure obligations regarding executive compensation in this prospectus and
our periodic reports and proxy statements, as applicable, and (3) exemptions from the requirements of holding a nonbinding advisory
vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

We could be an emerging growth company for up
to five years, although circumstances could cause us to lose that status earlier, including if the market value of our Common Shares
held by non-affiliates exceeds US$700 million as of any June 30